Fujifilm Diosynth Biotechnologies Expands Process-Development Capabilities
Fujifilm Diosynth Biotechnologies has announced continued expansion of its process-development capabilities with the investment of more than $5.6 million in new laboratories and equipment at both its sites in Billingham, the UK,and Research Triangle Park (RTP), North Carolina. This includes the installation of TAP ambr250 automated bioreactor system for microbial fermentations to be commercially installed at the company's Billingham, UK site.
Also at the UK site, three laboratories have been upgraded and refurbished to accommodate additional equipment, including new robotic chromatography platforms.
At the company's RTP, NC site, four new process-development laboratories have been added along with new equipment to allow greater flexibility for client project execution. This new equipment and expanded laboratory floor space for both process design and analytical support have increased the company’s development capacity at the site.
Source: Fujifilm Diosynth Biotechnologies